LGALS3 and colitis: In contrast, significantly lower number of regulatory, IL-10-producing DCs (p < 0.05; Figure 4H), which suppressed T cell-driven colon inflammation [16], was observed in Gal-3−/− animals 28 days after initial DSS administration.